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Abstract
Chronic Kidney Disease (CKD) affects 1 out of 7 adults in the United States and causes sig-
nificant morbidity and mortality. Development of tubulointerstitial fibrosis, and the accompanying
loss of functional tubular cells, leads to CKD progression. The Notch signaling pathway is re-
quired for renal development, however, sustained Notch activation in adult mice induces tubuloin-
terstitial fibrosis. Dual deletion of Par1a and Par1b, serine threonine kinases, in developing mouse
kidneys impaired Notch activation and resulted in the formation of abnormal glomeruli and prox-
imal tubules. Deletion of either Par1a or 1b does not affect kidney development.We hypothesize
that Par1a or 1b deletion in mice would protect against folic acid (FA) induced tubulointerstitial
fibrosis.
FA models of renal fibrosis were induced in Par1a WT and Par1a KO mice with intraperitoneal
injections of 250 mg/kg FA dissolved in 300 nM NaHCO3. Mice were examined 7 days after
injection—the time of earliest fibrosis and peak Notch expression. Sirius red collagen staining
was used to quantify the severity of fibrosis. Immunohistochemical staining for Notch signaling
components and Par1a were performed. It was observed that Par1a expression was increased af-
ter FA injection. Par1a colocalized in tubules with increased Jag1 expression. Sirius red staining
demonstrated less fibrosis in Par1a KO vs. WT mice.
Together, our results suggest Par1a deletion may be protective against renal fibrosis. Par1-Notch
interactions may be mediated by effects on Jag1. Par1-Notch signaling could be a novel target for
therapeutic intervention and potentially attenuate CKD progression.
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ABSTRACT 
Chronic Kidney Disease (CKD) affects 1 out of 7 adults in the United States and causes 
significant morbidity and mortality. Development of tubulointerstitial fibrosis, and the 
accompanying loss of functional tubular cells, leads to CKD progression. The Notch signaling 
pathway is required for renal development, however, sustained Notch activation in adult mice 
induces tubulointerstitial fibrosis. Dual deletion of  Par1a and Par1b, serine threonine kinases, in 
developing mouse kidneys impaired Notch activation and resulted in the formation of abnormal 
glomeruli and proximal tubules. Deletion of either Par1a or 1b does not affect kidney 
development.We hypothesize that Par1a or 1b deletion in mice would protect against folic acid 
(FA) induced tubulointerstitial fibrosis. 
FA models of renal fibrosis were induced in Par1a WT and Par1a KO mice with 
intraperitoneal injections of 250 mg/kg FA dissolved in 300 nM NaHCO3. Mice were examined 7 
days after injection—the time of earliest fibrosis and peak Notch expression. Sirius red collagen 
staining was used to quantify the severity of fibrosis. Immunohistochemical staining for Notch 
signaling components and Par1a were performed. It was observed that Par1a expression was 
increased after FA injection. Par1a colocalized in tubules with increased Jag1 expression. Sirius 
red staining demonstrated less fibrosis in Par1a KO vs. WT mice.  
 Together, our results suggest Par1a deletion may be protective against renal fibrosis. Par1-
Notch interactions may be mediated by effects on Jag1. Par1-Notch signaling could be a novel 
target for therapeutic intervention and potentially attenuate CKD progression.  
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